Skip to content

Psychedelic-assisted therapy: all studies

Page 40 of 293: studies 391 to 400 of 2,926, newest first. Back to the psychedelic-assisted therapy overview

Research

Psychedelic-assisted psychotherapy: hope and dilemma

The Lancet Regional Health - Europe September 1, 2023 The Lancet Regional Health – Europe 10 citations

Psychedelic-assisted psychotherapy: hope and dilemmaPsychedelic-assisted psychotherapy is an emerging therapeutic approach that combines the use of psychedelics (a subclass of hallucinogenic drugs) and psychotherapy for the treatment of post-traumatic stress disorder (PTSD) and treatment-resistant depression.Compared with current treatments for depression, psychedelic-assisted psychotherapy has...

DOI: 10.1016/j.lanepe.2023.100727 (opens in new tab) Dilemma Psychotherapist Psychoanalysis Epistemology

Psychedelic-Assisted Psychotherapy and Mindfulness-Based Cognitive Therapy: Potential Synergies

Mindfulness September 1, 2023 Richard Chambers, Devon Stoliker, Otto Simonsson 10 citations

Abstract Objectives The mindfulness-informed intervention that has so far received the most attention as an adjunct to psychedelic-assisted psychotherapy is Acceptance and Commitment Therapy (ACT), but little remains known about potential synergies between psychedelic-assisted psychotherapy and mindfulness-based interventions such as Mindfulness-Based Cognitive Therapy (MBCT). This paper...

DOI: 10.1007/s12671-023-02206-4 (opens in new tab) Full text (opens in new tab) Meditation Psychotherapist Mindfulness-based cognitive therapy Cognition +4

Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.

Psychedelic Medicine September 1, 2023 Megan Miller, William E Rosa, Alden Doerner Rinaldi et al. 9 citations

Psychedelic-assisted therapy (PAT) has re-emerged as a promising intervention for addressing mental health conditions and existential concerns. Despite growing enthusiasm, PAT may be difficult to integrate into mainstream health systems. The rich sacramental traditions of psychedelics, their centering of the human experience, proposed substrates of action, context-dependent outcomes, and highly...

Psychedelic Therapy—A New Paradigm of Care for Mental Health

JAMA August 31, 2023 Rachel Yehuda, Amy Lehrner 33 citations

An increasing number of clinicians and researchers have become interested in the potential of psychedelic drugs for the treatment of mental health disorders, including depression, anxiety, posttraumatic stress disorder, eating disorders, and addictions.1,2

[Ethics in the practice of psychedelic-assisted psychotherapy].

Revue Médicale Suisse August 23, 2023 Gabriel Thorens, Louise Penzenstadler, Federico Seragnoli et al. 2 citations

This article proposes 10 points considered essential on the ethics associated with the practice of psychotherapy assisted by psychedelics (PAP) : 1) respect of the legal framework (LStup) of the use of psychotropic drugs ; 2) adequately manage psychedelics (storage, production and safety) ; 3) announce adverse effects to the competent authority ; 4) guarantee a psychotherapeutic follow-up ; 5)...

Differences in attitudes and beliefs about psychedelic-assisted therapy among social workers, psychiatrists, and psychologists in the United States

Journal of Psychedelic Studies August 21, 2023 Stacey B. Armstrong, Adam W. Levin, Yitong Xin et al. 12 citations

Abstract Background and aims Because psychedelic-assisted therapy (PAT) is likely to be provided by interdisciplinary professional teams comprised of social workers, psychologists, and psychiatrists, understanding the acceptability of this treatment approach among these professional disciplines is essential as the treatment advances through approval processes at the Food and Drug...

The Therapeutic Alliance in Psychedelic-Assisted Psychotherapy: A Novel Target for Research and Interventions

Psychedelic Medicine August 18, 2023 Philip Kamilar-Britt, Elana B. Gordis, Mitch Earleywine 15 citations

Clinical trials support the promise of psychedelic-assisted therapy (PAT) and reveal potential mechanisms underlying efficacy. Out of necessity, initial studies of PAT have focused on feasibility and impact with special attention to acute responses to the molecules, but investigations of the psychotherapy components of PAT have lagged other work. Years of research on other forms of...

Psilocybin‐assisted psychotherapy for treatment‐resistant depression: Which psychotherapy?

International Journal of Mental Health Nursing August 17, 2023 Marie Crowe, Jenni Manuel, Dave Carlyle et al. 6 citations

Abstract This perspective paper explores the choice of psychotherapy for psilocybin‐assisted psychotherapy for treatment‐resistant depression. There is evidence to support the use of some psychotherapies in treating ‘treatment‐resistant’ depression, and emerging evidence for the efficacy of psilocybin. The next step which is the focus of this paper is to identify psychotherapies that are both...

“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin‐assisted psychotherapy

International Journal of Eating Disorders August 8, 2023 Maxine Boyd, Joshua Woolley, Amanda E. Downey et al. 7 citations

Abstract Objective This study invited providers who care for patients with eating disorders to inform engagement, communication, and collaboration with psilocybin‐assisted psychotherapy interventions. Method Medical and mental health providers who treat patients with eating disorders were recruited via professional referral networks and participant driven sampling from across California to...

DOI: 10.1002/eat.24041 (opens in new tab) Psilocybin Eating disorders Psychological intervention Psychotherapist +2

“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance

Research Square July 27, 2023 Claire Finkelstein, Olivia Soha, Alana Roy et al. 2 citations preprint

Abstract Background: Body Image Disturbance (BID) is the distorted experience of one’s body. BID presents a risk for the onset, maintenance and relapse of body dysmorphic disorder and eating disorders, including anorexia nervosa (AN). Current treatments tend to focus on the cognitive and behavioural aspects while overlooking the perceptual symptoms and BID frequently persists beyond physical...

DOI: 10.21203/rs.3.rs-3189970/v1 (opens in new tab) Full text (opens in new tab) Thematic analysis Psychological intervention Psychotherapist Psychoeducation +5